Join
Live feed
·
PRReleasevia Quantisnow
Advaxis, Inc. logo
Immunome Inc. logo

Ayala Pharmaceuticals Announces Completion of Enrollment in Phase 3 RINGSIDE Study Evaluating AL102 in Desmoid Tumors

ByQuantisnow·Wall Street's wire, on your screen.
ADXS· Advaxis, Inc.IMNM· Immunome Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ADXS (Advaxis, Inc.), IMNM (Immunome Inc.) and more on Quantisnow.